✦ LIBER ✦

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections

✍ Scribed by Chakrabarti, S; Collingham, K E; Osman, H; Fegan, C D; Milligan, D W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Value of Pre-emptive Therapy for Cyt

✍ V. Müller; A. Perrakis; J. Meyer; T. Förtsch; K. Korn; R.S. Croner; S. Yedibela; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Initial experience with oral valganciclo

✍ Clemens Aigner; Peter Jaksch; Guenther Winkler; Kriztina Czebe; Shahrokh Taghavi 📂 Article 📅 2005 🏛 Springer Vienna 🌐 English ⚖ 68 KB

Inital experience with oral valgancyclov

✍ C Aigner; P Jaksch; G Winkler; C Czebe; E Devyatko; S Taghavi; W Wisser; W Klepe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

CMV Prophylaxis Therapy—Better Option Th

✍ J Varghese; G Narasimman; R Perumalla; Venu Gopal; Vivekananthan; Olithselvan; M 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 48 KB

Oral valganciclovir as preemptive therap

✍ A. Busca; P. De Fabritiis; V. Ghisetti; T. Allice; M. Mirabile; G. Gentile; F. L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Risk-adapted pre-emptive therapy for cyt

✍ Mori, T; Okamoto, S; Matsuoka, S; Yajima, T; Wakui, M; Watanabe, R; Ishida, A; I 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB